Results 141 to 150 of about 13,947 (241)

Hidradenitis suppurativa pathogenesis:Extrinsic factors

While genetic predisposition and immune dysregulation are recognized as key contributors to the development of hidradenitis suppurativa, accumulating research points to the influence of extrinsic factors in the pathogenesis of this condition. This review
Naik, Haley B., Thomsen, Simon Francis, Nielsen, Valdemar Wendelboe   +2 more
core   +1 more source

Interventions for hidradenitis suppurativa

Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis that presents with inflammatory nodules, abscesses, sinus tracts, and scarring with predilection for intertriginous regions.
Robert Boyle, Robin Guelimi, Sivem Afach, Pei-Tzu Lin, Chiao-Ni Wen, Chun-Hsien Huang, Ching-Chi Chi, John R. Ingram, Chia-Ling Yu, Laurence le cleach, Cheng-Chen Tai   +10 more
core   +1 more source

Diffuse CD30‐Positive Cutaneous Infiltrate in a Clinically Suspected Hidradenitis Suppurativa Lesion: Histopathologic and Diagnostic Challenges

Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 809-814, September 2026.
ABSTRACT Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder affecting apocrine gland–bearing areas. We report a 38‐year‐old male with a lesion in the left axilla, initially clinically interpreted as HS and resistant to antibiotics.
R. Gervasi, G. L. Piazzetta, G. Soluri, C. Scigliano, C. Pelaia, V. Zuccalà, C. Gentile, N. Lobello, E. Allegra, E. Chiarella, N. Innaro   +10 more
wiley   +1 more source

Attitudes of dermatological patients towards digital health interventions: a cross‐sectional survey and cluster analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page e1264-e1274, September 2026.
Summary Background This study aimed to assess the acceptance of Germany's adoption of digital health interventions (DHI) among dermatology patientsand to identify patient clusters. Patients and Methods A cross‐sectional, quantitative survey on acceptability and (future) usage of DHIs was conducted among patients with chronic dermatological conditions ...
Patrick Reinders, Matthias Augustin, Marina Otten   +2 more
wiley   +1 more source

Hidradenitis suppurativa

, 2018
Hidradenitis suppurativa (HS), is a chronic disease with inflammatory changes in areas with apocrine glands. The disease presents as inflammatory nodules, abscesses, draining tunnels and scarring.
Pasternack, R. (Rafael), Tasanen, K. (Kaisa)   +1 more
core  

Einstellungen dermatologischer Patienten gegenüber digitalen Gesundheitsinterventionen: Eine Querschnittsbefragung und Clusteranalyse

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page 1264-1276, September 2026.
Zusammenfassung Hintergrund und Ziele Ziel dieser Studie war es, die Akzeptanz digitaler Gesundheitsinterventionen (DHI) bei Patienten in der Dermatologie zu bewerten und Patientengruppen zu identifizieren. Patienten und Methoden Eine quantitative Querschnittsbefragung zur Akzeptanz und (künftigen) Nutzung von DHI unter Patienten mit chronischen ...
Patrick Reinders, Matthias Augustin, Marina Otten   +2 more
wiley   +1 more source

Patient-reported outcomes in hidradenitis suppurativa: A review

, 2019
Hidradenitis suppurativa, also known as acne inversa, is a chronic recurrent inflammatory disease of the skin making management challenging and continuously evolving.
Vellaichamy, Gautham, Braunberger, Taylor L, Jones, Jessica L, Peacock, Anjelica, Hamzavi, Iltefat H, Nahhas, Amanda F   +5 more
core   +1 more source

 Which factors determine affected sites in hidradenitis suppurativa?

, 2019
info:eu-repo/semantics ...
Villani, Axel, Guillem, Philippe, Benhadou, Farida   +2 more
core  

Redefining “Comorbidity” in Dermatology: Beyond Terminology, Lessons From Other Specialties

JEADV Clinical Practice, Volume 5, Issue 3, Page 989-990, September 2026.
Patricia Garbayo‐Salmons, Mireia Moreno   +1 more
wiley   +1 more source

Future Integration of Biomarkers for Inflammatory Skin Diseases Into Daily Practice: A Survey Among a Multifaceted Group of Patients and Dermatological Care Providers

Experimental Dermatology, Volume 35, Issue 9, September 2026.
Across the investigated skin diseases, a therapeutic response biomarker was highly prioritized among patients and DCPs, but patients also often prioritized a biomarker for comorbidity development. Adoption barriers and facilitators differed between patients and DCPs.
Linda T. H. Godding, Elke M. G. J. de Jong, Sylvia van Beugen, Antoinette I. M. van Laarhoven, Els van der Pool, Nanda J. Olde, Debra Trampe, Hanna Niehues, Ilse van Ee, Annemarie Sluijmers, Robert Rissmann, Juul M. P. A. van den Reek, Marieke M. B. Seyger, the Next Generation ImmunoDermatology Consortium (NGID)   +13 more
wiley   +1 more source